Angel News
Angel News

Back to Homepage

11th June 2021

Blueberry Therapeutics secures £750,000 investment from NPIF

NPIF – Maven Equity Finance, managed by Maven Capital Partners and part of the Northern Powerhouse Investment Fund has invested £750,000 in Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections. The funding will support the business as it embarks on the next set of clinical trials for a new topical antifungal spray for the treatment of onychomycosis using its unique nanodelivery platform technology, as well as progressing other product development lines.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage